- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04420052
Effects of Osteopathic Manipulative Treatment in Chronic Non-allergic Rhinosinusitis
Effects of Osteopathic Manipulative Treatment in Chronic Non-allergic Rhinosinusitis: a Randomised Placebo-controlled Trial
Chronic Rhinosinusitis (CRS) is a chronic condition with limited therapeutic options. Moreover, the pathophysiology is poorly understood. The aim of this study is to evaluate the efficacy of osteopathic manipulative treatment (OMT) in the course of this condition by applying several techniques supposed to be related to the autonomic nervous system. Our hypothesis is that these techniques could have beneficial effects on inflammation and head symptoms in CRS.
Methods:
A sample of 90 patients diagnosed by ENT specialist will be randomly assigned to the OMT group or the placebo group. The placebo procedure will consist in using light touch around the nose, on the throat and on the thorax. Treatment and placebo protocols are composed of two visits at day 0 and day 30.
A general practitioner will determine the eligibility for the study.
The outcomes include Peak Nasal Inspiratory Flow (PNIF) measured five times: at day 0, 30 (twice each, before and after treatment) and 180 (once). The two groups will be compared regarding short and long term evolution.
The evolution of symptoms will be assessed by the Sino-nasal Outcome Test (SNOT-22) seven times: at day 0, 30, 60, 90, 120, 150 and 180. This outcome will be analyzed using mixed effect modelling
A Qualitative study will be conducted in the two groups to understand the patients' experiences during care.
This protocol has been approved by a french ethic committee (Comité de Protection des Personnes Sud Ouest et Outre-Mer II, 2020.04.09).
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Statistical analysis details:
PNIF middle term evolution:
If the two groups can be compared regarding their socio-demographics characteristics, a student's t-test will compare evolution (day 0 before treatment to day 30 before treatment) of the PNIF between groups.
If characteristics are different, a multivariate linear model will be applied.
PNIF long term evolution:
The same tests will be made. The evolution will be assessed between day 0 (before treatment) and day 180.
PNIF short term evolution:
The same tests will be made. The evolution will be assessed before and after treatment at day 0 and day 30.
SNOT-22 evolution:
Mixed effect model will assess the evolution of symptoms from day 0 to day 180
Response Shift detection:
For the SNOT-22, an Oort procedure will be performed in order to detect Response shift among individuals.
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Maxime Salmon
- Phone Number: +332 28 07 29 28
- Email: msalmon@idheo.com
Study Locations
-
-
-
Le Mans, France, 72000
- Cabinet ORL du Maine
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- age between 18 and 50
- Chronic rhinosinusitis diagnosed by ear, nose, and throat (ENT) specialist or general practitioner
- informed consent given
- registered under french social security system
Exclusion Criteria:
- contraindication to spine manipulation
- receiving other treatment for CRS during this study
- being pregnant
- being under legal protection
- withdrawal of consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: Placebo group
|
The osteopath will lay hands without movement on the nose, the throat and the thorax of patients. This procedure takes around 15 minutes. |
Experimental: OMT group
|
Osteopaths will executed several high velocity low amplitude (HVLA) techniques on the upper thoracic spine and cervical spine. These techniques are assumed to modulate the sympathetic cervical ganglia and reduce inflammation in chronic rhinosinusitis. This procedure takes around 15 minutes. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in peak nasal inspiratory flow (PNIF)
Time Frame: PNIF will be perform at day 0 (before treatment) and at day 30 (before treatment)
|
The aim of this outcome is to measure change in nasal airflow during maximal inspiration with a facial mask.
|
PNIF will be perform at day 0 (before treatment) and at day 30 (before treatment)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Sino-nasal Outcomes Test 22 (SNOT-22)
Time Frame: Patients will complete the questionnaire at baseline (day 0), day 30, day 60, day 90, day 120, day 150 and day 180 to assess the change over time
|
This is a symptom-based rhinosinusitis questionnaire.
Possible total scores range from 0 to 110, where a higher score indicates worse symptoms.
|
Patients will complete the questionnaire at baseline (day 0), day 30, day 60, day 90, day 120, day 150 and day 180 to assess the change over time
|
Patient-reported experience of care
Time Frame: Interview will occur at day 180
|
Individual interviews will enable to document the personal experience during effective or placebo treatment.
|
Interview will occur at day 180
|
Sort term change in peak nasal inspiratory flow (PNIF)
Time Frame: PNIF will be perform at day 0 (before and after treatment), day 30 (before and after treatment)
|
The aim of this outcome is to measure change before and after each treatment in nasal airflow during maximal inspiration with a facial mask.
|
PNIF will be perform at day 0 (before and after treatment), day 30 (before and after treatment)
|
long term change in peak nasal inspiratory flow (PNIF)
Time Frame: PNIF will be perform at day 0 (before treatment) and at day 180.
|
The aim of this outcome is to measure change in nasal airflow during maximal inspiration with a facial mask from base line to day 180.
|
PNIF will be perform at day 0 (before treatment) and at day 180.
|
Collaborators and Investigators
Investigators
- Principal Investigator: sebastien cambier, Institut des Hautes Etudes Osteopathiques de Nantes
- Study Director: maxime salmon, MsC, Institut des Hautes Etudes Osteopathiques de Nantes
- Study Chair: Marie Moreau, Institut des Hautes Etudes Osteopathiques de Nantes
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Osteonose
- 2019-A02907-50 (Other Identifier: Agence nationale de sécurité du médicament et produits de santé)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Rhinosinusitis Chronic
-
Unity Health TorontoCompletedChronic RhinosinusitisCanada
-
University of MiamiCompleted
-
Medtronic Surgical TechnologiesCompleted
-
University of MichiganNeilMed PharmaceuticalsCompletedChronic RhinosinusitisUnited States
-
Odense University HospitalCompleted
-
Taichung Veterans General HospitalCompletedPostoperative Care | Chronic RhinosinusitisTaiwan
-
Christiane HaaseActive, not recruitingAsthma | Chronic Rhinosinusitis (Diagnosis) | Chronic Rhinosinusitis With Nasal Polyps | Chronic Rhinosinusitis Without Nasal PolypsDenmark
-
Washington University School of MedicineCompletedChronic Rhinosinusitis (Diagnosis) | Allergic Rhinosinusitis | Chronic Eosinophilic RhinosinusitisUnited States
-
Icahn School of Medicine at Mount SinaiTivic Health SystemsRecruiting
Clinical Trials on Osteopathic manipulative treatment
-
Ecole d'ostéopathie de ParisUniversity of Paris 5 - Rene DescartesCompleted
-
Nantes University HospitalCompletedBreast Feeding, ExclusiveFrance
-
Good Samaritan Hospital Medical Center, New YorkUnknownHeadacheUnited States
-
Assistance Publique - Hôpitaux de ParisInstitut National de la Santé Et de la Recherche Médicale, France; University... and other collaboratorsCompletedSubacute and Chronic Non-specific Low Back PainFrance
-
New York Institute of TechnologyActive, not recruitingDistorted; Balance | Post-Concussion SymptomsUnited States
-
New York Institute of TechnologyRecruitingParkinson's Disease | ConstipationUnited States
-
Come CollaborationUniversity of ChietiCompleted
-
New York Institute of TechnologyWithdrawn
-
University of California, San DiegoEnrolling by invitation
-
Des Moines UniversityCompletedOsteopathy in Diseases Classified ElsewhereUnited States